Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-20

Clinical Trial Update: The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for MIND-USA studying mitigating ICU-associated neurological dysfunction in delirium and impaired cognition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Delirium, Impaired Cognition | Phase 3 | Status: COMPLETED | Results posted: 2019-08-20